Clinical trial · Observational
Spanish Registry of Digestive Tumours RETUD
A Descriptive, Multicentre, Observational Epidemiological Study on Digestive Tumours
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this observational study is to assess the current state of digestive tumours in Spain. By doing so, it seeks to enhance the quality of care, optimize the diagnosis and treatment of digestive tumours, and identify opportunities for improvement that can benefit patients. The study will investigate the epidemiological, biological, and clinical characteristics of digestive tumors diagnosed in patients aged 18 and older across healthcare centres in Spain. It also aims to generate knowledge and scientific evidence for events and situations that may impact on patients with digestive tumours (e.g. COVID-19 coronavirus pandemic). Furthermore, subject to the patient's consent, biological samples may be collected for use in translational research projects and for the identification of molecular markers that may be useful in healthcare decision-making.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bile Duct Cancer | Malignant Bile Duct Neoplasm | CURATED_BROADER | 0.80 |
| Colorectal Cancer (CRC) | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Digestive Cancers | — | UNRESOLVED | — |
| Hepatocellular Cancer (HCC) | Hepatocellular Carcinoma | CURATED_BROADER | 0.80 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (5)
- label
- Biliary Tract Cancer (BTC)
- description
- Patients diagnosed with cholangiocarcinoma or gallbladder carcinoma from 01-01-2017.
- label
- Hepatocellular Carcinoma (HCC)
- description
- Patients with hepatocellular carcinoma primary diagnosed from 01-01-2017 and treated with systemic therapy.
- label
- MSI-High Colorectal Cancer (MSI-H CRC)
- description
- Patients with MSI-High colorectal cancer (by PCR or IHQ) and primary pathological diagnosis from 01-01-2017.
- label
- Pancreatic Cancer
- description
- Patients with exocrine pancreatic cancer diagnosed from 01-01-2019.
- label
- Rectal Cancer
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male and female patients ≥18 years old diagnosed with oesophageal cancer, gastric cancer, pancreatic cancer, hepatocarcinoma, gallbladder and bile duct cancer, cancer of the small intestine, appendix and gastrointestinal stroma, colorectal cancer, anal canal cancer or digestive hereditary cancer. * Written informed consent available. Exclusion Criteria: * Patient for whom, for whatever reason, it is not possible to know or obtain the information necessary to complete the data collection base.
References
Publications (0)
Data not yet available